# Colorectal Metastasis Prevention International Trial 2

> **NCT03919461** · PHASE2 · RECRUITING · sponsor: **Assaf-Harofeh Medical Center** · enrollment: 200 (estimated)

## Conditions studied

- Colorectal Neoplasms

## Interventions

- **DRUG:** Propranolol and etodolac
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03919461
- **Lead sponsor:** Assaf-Harofeh Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-02-28
- **Primary completion:** 2027-02-28
- **Final completion:** 2027-02-28
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-04-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03919461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03919461, "Colorectal Metastasis Prevention International Trial 2". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03919461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*